Zhigang Tang

238 Jiefang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study.

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study.

Journal: Current oncology (Toronto, Ont.)

Published: September 04, 2022

CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.

CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.

Journal: Cell biology and toxicology

Published: June 04, 2022

Deep lymph node enlargement and renal failure caused by hypercalcemia‑associated sarcoidosis: A case report.

Deep lymph node enlargement and renal failure caused by hypercalcemia‑associated sarcoidosis: A case report.

Journal: Experimental and therapeutic medicine

Published: May 23, 2022

Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis.

Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis.

Journal: Cell death & disease

Published: June 05, 2021

Chitosan-based hydrogels with injectable, self-healing and antibacterial properties for wound healing.

Chitosan-based hydrogels with injectable, self-healing and antibacterial properties for wound healing.

Journal: Carbohydrate polymers

Published: May 06, 2021

Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.

Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling.

Journal: American journal of cancer research

Published: September 12, 2020

Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo.

Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo.

Journal: Pathology, research and practice

Published: September 11, 2020

Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma. An update meta-analysis.

Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma. An update meta-analysis.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: April 09, 2019

Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.

Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 31, 2018

Expression of TFPI-2 gene in pancreatic carcinoma and its prognostic significance

Expression of TFPI-2 gene in pancreatic carcinoma and its prognostic significance

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: December 24, 2008

Showing 1-10 of 10

Last Updated: 09/26/2026